The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
Abstract
PURPOSE: To quantify the relative and absolute excess risks (AER) of site-specific second cancers, in particular solid tumors, among long-term survivors of Hodgkin’s disease (HD) and to assess risks according to age at HD diagnosis, attained age, and time since initial treatment. PATIENTS AND METHODS: Data from 32,591 HD patients (1,111 25-year survivors) reported to 16 population-based cancer registries in North America and Europe (1935 to 1994) were analyzed. RESULTS: Two thousand one hundred fifty-three second cancers (observed-to-expected ratio [O/E] = 2.3; 95% confidence interval [CI] = 2.2 to 2.4), including 1,726 solid tumors (O/E = 2.0; 95% CI, 1.9 to 2.0) were reported. Cancers of the lung (observed [Obs] = 377; O/E = 2.9), digestive tract (Obs = 376; O/E = 1.7), and female breast (Obs = 234; O/E = 2.0) accounted for the largest number of subsequent malignancies. Twenty-five years after HD diagnosis, the actuarial risk of developing a solid tumor was 21.9%. The relative risk of solid neoplasms decreased with increasing age at HD diagnosis, however, patients aged 51 to 60 years at HD diagnosis sustained the highest cancer burden (AER = 79.2/10,000 patients/year). After a progressive rise in relative risk and AER of all solid tumors over time, there was an apparent downturn in risk at 25 years. Temporal trends and treatment group distribution for cancers of the esophagus, stomach, rectum, female breast, bladder, thyroid, and bone/connective tissue were suggestive of a radiogenic effect. CONCLUSION: Significantly increased risks of second cancers were observed in all HD age groups. Although significantly elevated risks of stomach, female breast, and uterine cervix cancers persisted for 25 years, an apparent decrease in relative risk and AER of solid tumors at other sites is suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DEVITA, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,436
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
Bhatia, S., Robison, L. L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., & Meadows, A. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341201 · Cited by 905
Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987
Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Izumi, S., et al. (1994) · Radiation Research · doi:10.2307/3578892 · Cited by 779
Bone Sarcomas Linked to Radiotherapy and Chemotherapy in Children
Tucker, M. A., D'Angio, G. J., Boice, J. D., Strong, L. C., Li, F. P., Stovall, M., Stone, B. J., Green, D. M., Lombardi, F., Newton, W., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709033171002 · Cited by 765
Self-citationRisk of Second Cancers after Treatment for Hodgkin's Disease
Tucker, M. A., Coleman, C. N., Cox, R. S., Varghese, A., & Rosenberg, S. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180203 · Cited by 718
Travis, W. D., Travis, L. B., & Devesa, S. S. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y · Cited by 582
Self-citationMultiplicative Models and Cohort Analysis
Breslow, N. E., Lubin, J. H., Marek, P., & Langholz, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477915 · Cited by 565
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Self-citationBreast Cancer After Treatment of Hodgkin's Disease
Hancock, S. L., Tucker, M. A., & Hoppe, R. T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.25 · Cited by 536
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
Travis, L. B., Curtis, R. E., Fraumeni, J. F., Boice, J. D., Storm, H., Andersson, M., Hall, P., Bergfeldt, K., Holowaty, E., Clarke, E. A., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1429 · Cited by 488
Self-citationSwerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., & Linch, D. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.498 · Cited by 476
Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen, F. E., Klokman, W. J., Hagenbeek, A., Noyon, R., van den Belt-Dusebout, A. W., van Kerkhoff, E. H., van Heerde, P., & Somers, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.2.312 · Cited by 443
Self-citationvan Leeuwen, F. E., Klokman, W. J., Veer, M. B. V., Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.487 · Cited by 436
Self-citationRadiation Dose and Second Cancer Risk in Patients Treated for Cancer of the Cervix
Boice, J. D., Engholm, G., Kleinerman, R. A., Blettner, M., Stovall, M., Lisco, H., Moloney, W. C., Austin, D. F., Bosch, A., Cookfair, D. L., et al. (1988) · Radiation Research · doi:10.2307/3577477 · Cited by 394
Self-citationSecond Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and Adolescence
Metayer, C., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., Joensuu, T., van Leeuwen, F. E., van’t Veer, M. B., Curtis, R. E., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2435 · Cited by 340
Self-citationRadiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood Cancer
Hawkins, M. M., Wilson, L. M. K., Burton, H. S., Potok, M. H. N., Winter, D. L., Marsden, H. B., & Stovall, M. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.270 · Cited by 330
Self-citationTucker, M. A., Jones, P. H. M., Boice, J. D., Robison, L. L., Stone, B. J., Stovall, M., Jenkin, R. D. T., Lubin, J. H., Baum, E. S., & Siegel, S. E. (1991) · PubMed · Cited by 303
Self-citationSecond cancers following pediatric Hodgkin's disease.
Wolden, S. L., Lamborn, K. R., Cleary, S. F., Tate, D. J., & Donaldson, S. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.536 · Cited by 268
Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Hagenbeek, A., van den Belt-Dusebout, A. W., Noyon, R., Boice, J. D., Burgers, J. M. V., & Somers, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1530 · Cited by 234
Self-citationSankila, R., Garwicz, S., Olsen, J. H., Döllner, H., Hertz, H., Kreuger, A., Langmark, F., Lanning, M., Möller, T., & Tulinius, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1442 · Cited by 221
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Le Vu, B., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<370::aid-ijc11>3.0.co;2-c · Cited by 193
Hodgkin's disease: Complications of therapy and excess mortality
Hoppe, R. T. (1997) · Annals of Oncology · doi:10.1093/annonc/8.suppl_1.s115 · Cited by 192
Long-term complications of treatment and causes of mortality after Hodgkin's disease
Hancock, S. L., & Hoppe, R. T. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80018-x · Cited by 179
Cancer Following Radiotherapy for Peptic Ulcer
Griem, M. L., Kleinerman, R. A., Boice, J. D., Stovall, M. A., Shefner, D., & Lubin, J. H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.842 · Cited by 96
Self-citationBenign and Malignant Thyroid Neoplasms After Childhood Irradiation for Tinea Capitis 2 3
Ron, E., & Modan, B. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/65.1.7 · Cited by 91
Tissue doses from radiotherapy of cancer of the uterine cervix
Stovall, M., Smith, S. A., & Rosenstein, M. (1989) · Medical Physics · doi:10.1118/1.596331 · Cited by 87
Self-citationCancer Mortality Following Radium Treatment for Uterine Bleeding
Inskip, P. D., Monson, R. R., Wagoner, J. K., Stovall, M., Davis, F. G., Kleinerman, R. A., & Boice, J. D. (1990) · Radiation Research · doi:10.2307/3577741 · Cited by 64
Self-citationLung Cancer After Hodgkin's Disease
Travis, L. B., Curtis, R. E., Bennett, W. P., Hankey, B. F., Travis, W. D., & Boice, J. D. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.17.1324 · Cited by 39
Self-citation
Cited by
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Self-citationLate cardiotoxicity after treatment for Hodgkin lymphoma
Aleman, B. M. P., van den Belt-Dusebout, A. W., De Bruin, M. L., van 't Veer, M. B., Baaijens, M. H. A., Boer, J. P. D., Hart, A. A. M., Klokman, W. J., Kuenen, M. A., Ouwens, G. M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-034405 · Cited by 746
Self-citationLong-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Aleman, B. M. P., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.131 · Cited by 716
Self-citationBreast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Travis, L. B., Hill, D. A., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., et al. (2003) · JAMA · doi:10.1001/jama.290.4.465 · Cited by 666
Self-citationSecond Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma
Schaapveld, M., Aleman, B. M. P., van Eggermond, A. M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., Roesink, J., Raemaekers, J. M. M., de Boer, J. P., Zijlstra, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505949 · Cited by 637
Self-citation
Metadata
- Authors
- Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., Andersson, M., Wiklund, T., Joensuu, T., van’t Veer, M. B., Stovall, M., Gospodarowicz, M., & Travis, L. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-08-15
- Volume
- 20
- Issue
- 16
- Pages
- 3484-3494
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2098179714
- Cited by
- 565
- References
- 31
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.